Koers Peloton Therapeutics, Inc.
Aandelen
PLTX
US70614L1044
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 01-11-17 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 01-01-11 |
David Chang
BRD | Director/Board Member | 64 | 01-02-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,12% | 126 mld. | |
+25,25% | 119 mld. | |
+25,56% | 27,95 mld. | |
-19,51% | 20,5 mld. | |
-14,36% | 17,12 mld. | |
-15,63% | 16,1 mld. | |
-46,67% | 14,97 mld. | |
+11,89% | 14,84 mld. | |
+57,74% | 14,38 mld. |